Logo image of CBRE

CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

NYSE:CBRE - New York Stock Exchange, Inc. - US12504L1098 - Common Stock - Currency: USD

143.18  +0.67 (+0.47%)

After market: 143.18 0 (0%)

Fundamental Rating

5

Overall CBRE gets a fundamental rating of 5 out of 10. We evaluated CBRE against 65 industry peers in the Real Estate Management & Development industry. CBRE has an average financial health and profitability rating. CBRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CBRE had positive earnings in the past year.
CBRE had a positive operating cash flow in the past year.
In the past 5 years CBRE has always been profitable.
CBRE had a positive operating cash flow in each of the past 5 years.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.81%, CBRE belongs to the top of the industry, outperforming 89.23% of the companies in the same industry.
Looking at the Return On Equity, with a value of 12.13%, CBRE belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
CBRE has a Return On Invested Capital of 7.14%. This is amongst the best in the industry. CBRE outperforms 92.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 5.47%.
Industry RankSector Rank
ROA 3.81%
ROE 12.13%
ROIC 7.14%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CBRE's Profit Margin of 2.74% is fine compared to the rest of the industry. CBRE outperforms 72.31% of its industry peers.
In the last couple of years the Profit Margin of CBRE has declined.
CBRE has a Operating Margin of 4.29%. This is in the better half of the industry: CBRE outperforms 64.62% of its industry peers.
In the last couple of years the Operating Margin of CBRE has declined.
The Gross Margin of CBRE (19.59%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 4.29%
PM (TTM) 2.74%
GM 19.59%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBRE is destroying value.
CBRE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
CBRE has a worse debt/assets ratio than last year.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CBRE has an Altman-Z score of 3.50. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CBRE (3.50) is better than 80.00% of its industry peers.
CBRE has a debt to FCF ratio of 5.05. This is a neutral value as CBRE would need 5.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.05, CBRE is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CBRE has a Debt/Equity ratio of 0.74. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.74, CBRE perfoms like the industry average, outperforming 44.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.05
Altman-Z 3.5
ROIC/WACC0.81
WACC8.87%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

CBRE has a Current Ratio of 1.00. This is a bad value and indicates that CBRE is not financially healthy enough and could expect problems in meeting its short term obligations.
CBRE has a worse Current ratio (1.00) than 67.69% of its industry peers.
CBRE has a Quick Ratio of 1.00. This is a bad value and indicates that CBRE is not financially healthy enough and could expect problems in meeting its short term obligations.
CBRE has a worse Quick ratio (1.00) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

CBRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.27%, which is quite impressive.
CBRE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.61% yearly.
The Revenue has grown by 13.14% in the past year. This is quite good.
The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)40.27%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%10.26%
Revenue 1Y (TTM)13.14%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%12.29%

3.2 Future

CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.71% yearly.
CBRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.68% yearly.
EPS Next Y19.05%
EPS Next 2Y18.8%
EPS Next 3Y17.91%
EPS Next 5Y16.71%
Revenue Next Year12.89%
Revenue Next 2Y11.06%
Revenue Next 3Y9.27%
Revenue Next 5Y8.68%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

CBRE is valuated quite expensively with a Price/Earnings ratio of 27.59.
Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than 76.92% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. CBRE is around the same levels.
With a Price/Forward Earnings ratio of 19.85, CBRE is valued on the expensive side.
83.08% of the companies in the same industry are more expensive than CBRE, based on the Price/Forward Earnings ratio.
CBRE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.59
Fwd PE 19.85
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CBRE is valued a bit cheaper than the industry average as 72.31% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 73.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.59
EV/EBITDA 19.88
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

CBRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CBRE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CBRE's earnings are expected to grow with 17.91% in the coming years.
PEG (NY)1.45
PEG (5Y)4.17
EPS Next 2Y18.8%
EPS Next 3Y17.91%

0

5. Dividend

5.1 Amount

No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield N/A

CBRE GROUP INC - A

NYSE:CBRE (7/3/2025, 7:07:41 PM)

After market: 143.18 0 (0%)

143.18

+0.67 (+0.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-23 2025-07-23/bmo
Inst Owners99.11%
Inst Owner Change0.73%
Ins Owners0.52%
Ins Owner Change7.89%
Market Cap42.68B
Analysts81.05
Price Target151.27 (5.65%)
Short Float %1.38%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.34%
Min EPS beat(2)2.25%
Max EPS beat(2)10.42%
EPS beat(4)4
Avg EPS beat(4)7.16%
Min EPS beat(4)2.25%
Max EPS beat(4)10.89%
EPS beat(8)8
Avg EPS beat(8)8.24%
EPS beat(12)11
Avg EPS beat(12)8.13%
EPS beat(16)14
Avg EPS beat(16)13.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-1.96%
Max Revenue beat(2)-0.83%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)0.71%
Revenue beat(8)4
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)0.26%
Revenue beat(16)9
Avg Revenue beat(16)0.34%
PT rev (1m)2.49%
PT rev (3m)-5.6%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)-6.92%
EPS NY rev (1m)0.38%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 27.59
Fwd PE 19.85
P/S 1.16
P/FCF 31.59
P/OCF 25.81
P/B 5.15
P/tB N/A
EV/EBITDA 19.88
EPS(TTM)5.19
EY3.62%
EPS(NY)7.21
Fwd EY5.04%
FCF(TTM)4.53
FCFY3.17%
OCF(TTM)5.55
OCFY3.88%
SpS123.25
BVpS27.78
TBVpS-1.59
PEG (NY)1.45
PEG (5Y)4.17
Profitability
Industry RankSector Rank
ROA 3.81%
ROE 12.13%
ROCE 10.18%
ROIC 7.14%
ROICexc 7.73%
ROICexgc 16.05%
OM 4.29%
PM (TTM) 2.74%
GM 19.59%
FCFM 3.68%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexcg growth 3Y-10.49%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.05
Debt/EBITDA 2.69
Cap/Depr 43.72%
Cap/Sales 0.82%
Interest Coverage 3.96
Cash Conversion 72.84%
Profit Quality 134.43%
Current Ratio 1
Quick Ratio 1
Altman-Z 3.5
F-Score6
WACC8.87%
ROIC/WACC0.81
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)40.27%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%10.26%
EPS Next Y19.05%
EPS Next 2Y18.8%
EPS Next 3Y17.91%
EPS Next 5Y16.71%
Revenue 1Y (TTM)13.14%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%12.29%
Revenue Next Year12.89%
Revenue Next 2Y11.06%
Revenue Next 3Y9.27%
Revenue Next 5Y8.68%
EBIT growth 1Y23.47%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year54.59%
EBIT Next 3Y22.81%
EBIT Next 5Y17.36%
FCF growth 1Y35.17%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y29.44%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%